A CRISPR/Cas9-Engineered <i>ARID1A</i> -Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
Yuan‐Hung Lo(The University of Texas MD Anderson Cancer Center), Calvin J. Kuo(Stanford University), Jonathan S. Weissman(Howard Hughes Medical Institute), Amanda T. Mah(Stanford Medicine), Chiung-Ying Chang(Stanford Medicine), Kevin S. Kolahi(Stanford Medicine), Christina Curtis(Broad Institute), Kasper Karlsson(Stanford Medicine), Sunny J. Jones(Columbia University), Andrea Califano(Herbert Irving Comprehensive Cancer Center), Ajay Nair(Columbia University), Ilya Shmulevich(University of Southern California), Haian Fu(Emory University), Bahar Tercan(Institute for Systems Biology), Alexandra Sockell(Stanford Medicine), Teri A. Longacre(Stanford Medicine), Jin Chen(Howard Hughes Medical Institute), Hang Xu(First Affiliated Hospital of Shihezi University Medical College), A. Krokhotin(University of North Carolina at Chapel Hill), Walter D. Sobba(Stanford Medicine), Yuhong Du(North University of China), José A. Seoane(Stanford University)
Cited by 166
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
|Cell|2011|2.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Molecular Chaperones and Protein Quality Control
|Cell|2006|1.6k